Norway has removed the vaccine against Covid-19 made by AstraZeneca from its inoculation campaign, Prime Minister Erna Solberg said.
Solberg said on Wednesday that the decision was based on the advice of a committee of experts and the Norwegian Institute of Public Health (FHI), which recommended excluding the shots made by AstraZeneca and Johnson & Johnson due to the risk of very rare but serious side effects, DPA news agency reported.
Norway is also extending its temporary halt on the use of the Johnson & Johnson shot, but has not excluded it from its inoculation campaign for now, Solberg said.
The government is currently looking into offering the Johnson & Johnson vaccine to those willing to receive it.
The country had not yet started using the Johnson & Johnson jab.
The committee's recommendations were based partly on the current situation in Norway, where infections are low compared to other countries.
Norway stopped using the Astrazeneca's vaccine on March 11 as a precautionary measure after rare blood clots occurred after vaccination, including deaths. Some 138,000 people had received the vaccine up until then.
Denmark excluded the AstraZeneca vaccine from its inoculation programme just over a month ago.
--IANS
int/pgh
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)